Unbalance Glycometabolic in Elderly Woman None Diabetic COPD Patients

Tiziana Ciarambino, Mauro Giordano, Giovanna Menco, Bruno Moncharmont, Nicola Ferrara, Giuseppe Paolisso, Cecilia Politi


Background: It has been estimated that by 2020, the Chronic Obstructive Pulmonary Disease (COPD) will be the third place among the most important causes of death in all over the world. Studies focusing on risk factors that influence the admission or readmission to the hospital are limited. The administration of medications can contribute to unplanned readmission. Moreover, in the course of COPD, treatment with cortisone determines a high risk of worsening of glucose control. The guidelines on the management of COPD do not address this issue in detail, although the number of COPD patients with diabetes mellitus is considerable and significant. Clinical studies designed specifically on this population are needed in order to identify effective and safe therapeutic pathways.

Methods: We conducted an observational, descriptive study in a health area of the Molise Region that included 300 elderly subjects aged >= 65 and followed from June 2012 to June 2013.

Results and Conclusions: Our preliminary study revealed that the prevalence of unbalance glycometabolic (as indicated by HbA1c > 7%) in COPD patients was > 50%. In particular, this difference was more frequent in COPD woman patients and it warrants further investigation.

J Endocrinol Metab. 2013;3(4-5):91-97
doi: https://doi.org/10.4021/jem194e


Elderly; COPD; Glicometabolic unbalance; Gender

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.